OPC Pharmaceutical Joint Stock Company

HOSE:OPC Stock Report

Market Cap: ₫1.5t

OPC Pharmaceutical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Huong Thi Pham

Chief executive officer

₫4.3b

Total compensation

CEO salary percentagen/a
CEO tenure3.4yrs
CEO ownershipn/a
Management average tenure8.3yrs
Board average tenure3.2yrs

Recent management updates

Recent updates

CEO

Huong Thi Pham

3.4yrs

Tenure

₫4,337,033,433

Compensation

Mrs. Huong Thi Xuan Pham has been Chief Executive Officer of OPC Pharmaceutical Joint Stock Company since July 14, 2021 and is its Director since April 27, 2023.

Leadership Team

NamePositionTenureCompensationOwnership
Huong Thi Pham
CEO & Director3.4yrs₫4.34bno data
Anh Thi Le
Deputy General Manager11.1yrs₫1.43bno data
Cuong Ha
Deputy General Manager8.3yrs₫1.20bno data
De Nguyen
Chief Accountant10.5yrsno data0.073%
₫ 1.1b
Hong Nguyen
Corporate Governance & Secretary1.3yrsno datano data

8.3yrs

Average Tenure

Experienced Management: OPC's management team is seasoned and experienced (8.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Huong Thi Pham
CEO & Director1.7yrs₫4.34bno data
Vuong Trinh
Directorno data₫730.33m13.82%
₫ 209.3b
Vinh Thi Han
Director3.2yrs₫444.78mno data
Nhung Phuong
Deputy Chairman3.2yrs₫444.78mno data
Nhung Thi Nguyen
Member of the Board of Supervisors3.2yrsno datano data
Hong Thi Kieu
Head of the Board of Supervisors3.2yrsno datano data
Nguyen Vu
Member of the Supervisory Board1.7yrsno datano data
Hoang Son
Chairman of the Board1.7yrs₫493.33mno data

3.2yrs

Average Tenure

Experienced Board: OPC's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 23:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OPC Pharmaceutical Joint Stock Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution